Skip to main content

Reporter Jan 18 2013

Photo: Discovery Lecture

Jan. 17, 2013—Brenda Schulman, Ph.D., of St. Jude Children’s Research Hospital, discusses ubiquitin and ubiquitin-like proteins during her recent Flexner Discovery Lecture.

Read more


Flu season’s rise highlights crucial role of vaccination

Jan. 17, 2013—While this year’s flu season appears to be slowing down in some parts of the country, we’re not out of the woods yet, caution officials at Vanderbilt University Medical Center.

Read more


Study helps define pancreatic cancer’s cellular origins

Jan. 17, 2013—Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments.

Read more


Basketball player’s project scores big for young patients

Jan. 17, 2013—For Gabby Smith, a senior on the Vanderbilt University Women’s basketball team, a box of crayons is more than a carton of colored wax sticks used to scribble on paper.

Read more


New app takes emergency medicine information mobile

Jan. 17, 2013—A Vanderbilt Emergency Medicine physician has created an application for smart phones and tablets to help emergency care providers stay on top of the latest research and newest treatment techniques.

Read more


Zinc: a new antibiotic target?

Jan. 17, 2013—It may be possible to fight hospital-acquired pathogens like Acinetobacter baumannii by targeting the bacterium’s need for the nutrient metal zinc.

Read more


AstraZeneca, VU collaborate to develop new treatments for major brain disorders

Jan. 14, 2013—AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more